FMR LLC 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 3,372,850 6.387% |
-1,281,426 (-27.53%) |
Filing |
| 2024-03-11 08:19 am Purchase |
2024-03-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 4,654,276 10.809% |
1,885,580 (+68.10%) |
Filing |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 2,768,696 6.430% |
-1,110,427 (-28.63%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 3,879,123 9.192% |
410,292 (+11.83%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 3,468,831 8.406% |
3,468,831 (New Position) |
Filing |